Tag: United States Hospital-Acquired Pneumonia (HAP) Drugs Market By Application Size Analyst Report 2031

United States Hospital-Acquired Pneumonia (HAP) Drugs Market by Application Hospital-acquired pneumonia (HAP) poses a significant healthcare challenge in the United States, with a notable impact on morbidity and mortality rates among hospitalized patients. The demand for effective drugs to manage HAP continues to drive innovation and investment in the pharmaceutical industry. In the U.S., the…